Maria Karasarides: I’m very happy to share that we are launching GUIDE.MRD, a new Innovative Health Initiative (IHI) project.

Maria Karasarides, Vice President at Bristol Myers Squibb, recently shared on LinkedIn:

“I’m very happy to share that we are launching GUIDE.MRD, a new Innovative Health Initiative (IHI) project set to advance the use of ctDNA testing so that we can develop better blood tests to detect and treat cancer.

GUIDE.MRD, our new European consortium of public and private partners, is one of the very first IHI projects with a total budget of EUR 35 million and a 5-year runway to deliver diagnostic innovation that can meaningfully equip physicians and patients as they make important treatment decisions.

Thank you IHI and Horizon Europe for supporting our work.  Together with my collaborators Klaus Pantel and Claus Lindbjerg Andersen, I stand in complete appreciation of all the GUIDE.MRD partners.  Please stay tuned – In the coming weeks we will be releasing more info on our project and, importantly, all the faces that are driving GUIDE.MRD and our ambition to improve outcomes for people with cancer.”

Source: Maria Karasarides/LinkedIn